Journal of the Korean Society of Radiology (한국방사선학회논문지)

The Korean Society of Radiology (한국방사선학회)
권호 표지
DOI QR코드

DOI QR Code

Decrease of Irradiated Volume using Rotational Treatment by Avoidance Sector in Radiation Therapy for Esophageal Cancer

식도암의 방사선치료에서 부분 각도에 의한 회전 치료를 이용한 조사체적의 감소

  • Hwang, Chulhwan (Departments of Radiology, Masan University) ;
  • Kim, Seong Hu (Departments of Radiology, Masan University) ;
  • Koo, Jae Heung (Departments of Radiology, Masan University) ;
  • Son, Jong Ki (Departments of Radiation Oncology, Pusan National University Hospital)
  • 황철환 (마산대학교 방사선과) ;
  • 김성후 (마산대학교 방사선과) ;
  • 구재흥 (마산대학교 방사선과) ;
  • 손종기 (부산대학교병원 방사선종양학과)
  • Received : 2018.06.25
  • Accepted : 2018.10.31
  • Published : 2018.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

In this study, plans to apply 3D conformal radiotherapy, intensity modulated radiotherapy, and volumetric intensity modulated arc radiotherapy to esophageal cancer radiotherapy were compared. In particular, arc therapy was applied to reduce irradiated volume and spread of low-dose during intensity modulated radiation therapy and volumetric intensity modulated arc radiotherapy by limiting part of irradiated angle, in order to compare target doses and dose for surrounding normal tissues of the two methods and those of 3D conformal radiotherapy. No significant difference in target dose was found among the three methods. The 5 Gy volume(V5) of the lung showed 56.53% of conformal radiotherapy, 52.03% of intensity modulated radiotherapy, and 47.84% of volumetric modulated arc therapy(CRT-IMRT p=0.035, CRT-VMAT p<0.001, IMRT-VMAT p<0.001). The 10 Gy volume(V10) showed a significant difference in conformal radiotherapy 35.12%, intensity modulated radiotherapy 34.04%, and volumetric modulated arc radiotherapy 33.28%, showing significant difference in intensity modulated radiotherapy(p=0.018), volumetric modulated arc therapy(p=0.035), no significant difference in dose was found at 20 Gy volume. The mean dose and 20 Gy volume of the heart were not significantly different according to the treatment plan, but the 30 and 40 Gy volumes were 37.16% and 22.46% in the volumetric modulated arc radiotherapy, showing significant differences(p=0.028) in comparison with conformal radiotherapy. It is believed that, by limiting part of the irradiated angle during intensity modulated radiotherapy and volumetric intensity modulated arc radiotherapy, the irradiated volume and, thereby, the 5-10 Gy area and toxicity of the lung can be reduced while maintaining dose distribution of the target dose.

세기변조방사선치료와 입체적세기조절회전치료 시 조사체적과 선량 퍼짐 현상을 줄이기 위한 방법으로 조사 각도를 제한하는 부분 각도에 의한 회전치료 기능을 적용하여 표적체적과 주변 정상장기의 선량에 대해 입체조형방사선치료와 비교 분석하였다. 치료계획에 따른 표적체적의 선량분포는 통계적으로 유의한 차이를 확인할 수 없었으며, 폐의 5 Gy(V5) 체적에서 입체조형방사선치료 56.53%, 세기변조방사선치료 52.03%, 입체적세기조절회전치료 47.84%를 나타내어 유의한 차이를 나타내었다(CRT-IMRT p=0.035, CRT-VMAT p<0.001, IMRT-VMAT p<0.001). 10 Gy 체적(V10)에서는 입체조형방사선치료 35.12%, 세기변조방사선치료 34.04%, 입체적세기조절회전치료 33.28%를 보여, 입체조형방사선치료와 세기변조방사선치료(p=0.018), 입체적세기조절회전치료(p=0.035)에서 유의한 차이를 나타내었으나 20 Gy 체적(V20)에서는 유의한 선량 차이를 확인할 수 없었다. 심장의 평균선량과 20 Gy 체적은 치료계획에 따라 유의한 차이를 확인할 수 없었으나, 30, 40 Gy 체적은 입체적세기조절회전치료에서 37.16%, 22.46%를 나타내어 입체조형방사선치료와 비교에서 유의한 차이(p=0.028)를 보였다. 이와 같이 조사체적 감소에 따른 폐의 저 선량 체적(V5, V10)의 감소를 확인할 수 있었으며, 세기변조방사선치료와 입체적세기조절회전치료 시 조사 각도를 일부 제한함으로써 표적체적의 선량분포는 동일하게 유지함과 동시에 조사체적을 줄일 수 있었다. 이로 인해 폐의 선량 퍼짐 현상의 감소로부터 폐의 독성을 낮추는데 기여할 수 있을 것으로 사료된다.

Keywords

References

  1. Report of national cancer registration, Korea Cancer Center, 2017.
  2. J. Staffurth J, "A review of the clinical evidence for intensity-modulated radiotherapy," Clinical Oncology, Vol. 22, No. 8, pp. 643-657, 2010. https://doi.org/10.1016/j.clon.2010.06.013
  3. P. Dirix, B. Vanstraelen, M Jorissen, "Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy," International Journal of Radiation Oncology Biology Physics, Vol. 78, No. 4, pp. 998-1004, 2010. https://doi.org/10.1016/j.ijrobp.2009.09.067
  4. A. W. Pederson, J. Fricano, D Correa, "Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose volume histogram parameters to limit genitourinary and gastrointestinal toxicity," International Journal of Radiation Oncology Biology Physics, Vol. 82, No. 1, pp. 235-241, 2012. https://doi.org/10.1016/j.ijrobp.2010.09.058
  5. C. S. Mayo, L. Ding, A. Addesa, "Initial experience with volumetric IMRT (RapidArc) for intracranial stereotactic radiosurgery," International Journal of Radiation Oncology Biology Physics, Vol. 78, No. 5, pp. 1457-1466, 2010. https://doi.org/10.1016/j.ijrobp.2009.10.005
  6. D. Wolff, F. Stieler, G. Welzel, "Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer," Radiotherapy & Oncology, Vol. 93, No. 2, pp. 226-233, 2009. https://doi.org/10.1016/j.radonc.2009.08.011
  7. H. H. Liu, X. Wang, L. Dong, "Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small cell lung cancer," International Journal of Radiation Oncology Biology Physics, Vol. 58, No. 4, pp. 1268-1279, 2004. https://doi.org/10.1016/j.ijrobp.2003.09.085
  8. E. J. Hall, "Intensity-modulated radiation therapy, proton, and the risk of second cancers," International Journal of Radiation Oncology Biology Physics, Vol. 65, No. 1, pp. 1-7, 2006. https://doi.org/10.1016/j.ijrobp.2006.01.027
  9. V. G. Mary, A. P. James, E. Bahman, "Clinical dose volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer(NSCLA)," International Journal of Radiation Oncology Biology Physics, Vol. 45, No. 2, pp. 323-329, 1999. https://doi.org/10.1016/S0360-3016(99)00183-2
  10. Z. Wu, C. Xie, M. Hu, "Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option?," Journal of Applied Clinical Medical Physics. Vol. 15, No. 3, pp. 93-101, 2014. https://doi.org/10.1120/jacmp.v15i3.4641
  11. ICRU Report 62(supplement to ICRU 50), Prescribing, recording and reporting photon beam therapy, International Commission on Radiation Units and Mesurements, Maryland, USA, 1999.
  12. Radiation Therapy Oncology Group, RTOG 0436 A phase III trial evaluating the addiation of cetuximab to paclitaxel cisplatin, and radiation for patients with esophageal cancer who are treated without surgery, Philadelphia, 2009.
  13. N. J. Lomax, S. G. Scheib, "Quantifying the degree of conformity in radiosurgery treatment planning," International Journal of Radiation Oncology Biology Physics, Vol. 55, No. 5, pp. 1409-1419, 2003. https://doi.org/10.1016/S0360-3016(02)04599-6
  14. A. Riet, A, C. Mak, M. A. Moerland, "A conformation number to quantify the degree of conformity in brachytherapy and external beam irradiation: application to prostate," International Journal of Radiation Oncology Biology Physics, Vol. 37, No. 3, pp. 731-736, 1997. https://doi.org/10.1016/S0360-3016(96)00601-3
  15. D. Palma, E. Vollans, K. James, "Volumetric modulated arc therapy for delivery of prostate radiotherapy: Comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy," International Journal of Radiation Oncology Biology Physics, Vol. 72, No. 4, pp. 996-1001, 2008. https://doi.org/10.1016/j.ijrobp.2008.02.047
  16. C. M. Nutting, J. L. Bedford, V. P. Cosgrove, "A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy," Radiotherapy & Oncology. Vol. 61, No. 2, pp. 157-163, 2001. https://doi.org/10.1016/S0167-8140(01)00438-8
  17. H. H. Liu, X. Wang, L. Dong, "Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small cell lung cancer," International Journal of Radiation Oncology Biology Physics, Vol. 58, No. 4, pp. 1268-1279, 2004. https://doi.org/10.1016/j.ijrobp.2003.09.085
  18. A. Fogliata, A. Clivio, G. Nicolini, "Intensity modulation with photons for benign intracranial tumours: a planning comparison of volumetric single arc, helical arc and fixed gantry techniques," Radiotherapy & Oncology. Vol. 89, No. 3, pp. 254-262, 2008. https://doi.org/10.1016/j.radonc.2008.07.021
  19. G. M. Cattaneo, I. Delloca, S. Broggi, "Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC," Radiotherapy & Oncology, Vol. 83, No. 3, pp. 310-318, 2008.
  20. R. Florain, K. Michael, S. Daniel, "Reducing the low-dose lung radiation for central lung tumors by restricting the IMRT beams and arc arrangement," American Association of Medical Dosimetrists, Vol. 37, No. 3, pp. 280-286, 2012.
  21. D. B. Ingrid, G. E. Marielle, H. Van, "High-dose radiotherapy in inoperable nonsmall cell lung cancer: Comparison of volumetric modulated arc therapy, dynamic IMRT and 3D conformal radiotherapy," Medical Dosimetry. Vol. 37, No. 4, pp. 353-357, 2012. https://doi.org/10.1016/j.meddos.2011.12.002
  22. C. H. Song, H. Pyo, S. H. Moon, "Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy," International Journal of Radiation Oncology Biology Physics, Vol. 78, No. 3, pp. 651-658, 2010. https://doi.org/10.1016/j.ijrobp.2009.08.068
  23. S. Wang, Z. Liao, X. Wei, "Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)," International Journal of Radiation Oncology Biology Physics, Vol. 66, No. 5, pp. 1399-1407, 2006. https://doi.org/10.1016/j.ijrobp.2006.07.1337
  24. M. Meadors, J. Floyd, M. C. Perry, "Pulmonary toxicity of chemotherapy," Seminars in Oncology, Vol. 33, No. 1, pp. 98-105, 2006 https://doi.org/10.1053/j.seminoncol.2005.11.005
  25. C. Y. Lin, W. Y. Huang, Y. M. Jen, "Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy," Diseases of the Esophagus, Vol. 27, No. 6, pp. 585-590, 2014. https://doi.org/10.1111/dote.12144